跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
江 玲玲
成員
,
臺北醫學大學胸腔醫學研究中心
https://orcid.org/0000-0002-6482-6907
h-index
748
引文
14
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1993 …
2021
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(72)
類似的個人檔案
(6)
指紋
查看啟用 Ling-Ling Chiang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
66%
Artificial Respiration
51%
Respiratory Care
48%
Six Minute Walk Test
40%
Continuous Positive Airway Pressure
35%
Forced Expiratory Volume
31%
Asthma
30%
Hypercapnia
30%
Respiratory Muscle
28%
Oxygen Therapy
28%
Breathing
26%
Respiratory Failure
24%
Carbon Dioxide
24%
Obstructive Sleep Apnea
24%
Extubation
24%
Nasal Cannula
24%
Rehabilitation Engineering
24%
Bronchiectasis
24%
Forced Vital Capacity
23%
Disease
23%
Secretion (Process)
23%
Nitric Oxide
22%
Endurance Training
22%
Acute Respiratory Distress Syndrome
20%
Lung Function Test
20%
Coughing
19%
Intubation
18%
Exercise Tolerance
18%
Exercise
17%
Randomized Controlled Trial
17%
Lung Function
17%
Dyspnea
16%
Limb
16%
Exercise Intolerance
15%
Combination Therapy
15%
Walk Test
15%
Airway Obstruction
14%
Serositis
14%
Hypoxemia
14%
Quality of Life
14%
Heart Failure
13%
Mucus
13%
Chest Physiotherapy
13%
Acute Lung Injury
13%
Air Trapping
13%
Physiotherapy
13%
Ischemia
12%
Walking Distance
12%
Home Respiratory Care
12%
Prostaglandin Synthase Inhibitor
12%
Nursing and Health Professions
Obstructive Lung Disease
100%
Artificial Respiration
54%
Continuous Positive Airway Pressure
43%
Functional Status
39%
Physiotherapy
37%
Six Minute Walk Test
34%
Asthma
30%
Walking Distance
29%
Dyspnea
29%
Quality of Life
28%
Respiratory Care
28%
Respiratory Failure
24%
Meta Analysis
24%
Nasal Cannula
24%
Coughing
24%
Extubation
24%
Bronchiectasis
24%
Rehabilitation Engineering
24%
Confidence Interval
21%
Disease
19%
Forced Vital Capacity
19%
Oxygen Therapy
19%
Amyotrophic Lateral Sclerosis
18%
Short Form 36
18%
Forced Expiratory Volume
17%
Chronic Respiratory Failure
17%
Functional Independence Measure
17%
Hypoxemia
16%
Barthel Index
15%
Combination Therapy
15%
Oxygenation
14%
Breathing Exercise
14%
Mobilization
14%
Tidal Volume
14%
Systematic Review
13%
Heart Failure
13%
Airway Obstruction
13%
Walk Test
13%
Arterial Blood Gas
13%
Neuromuscular Disease
13%
Chronic Bronchitis
12%
Integrated Delivery System
12%
Breathing Disorder
12%
Lung Capacity
12%
Phorbol
12%
Immunosuppressive Agent
12%
Pulse Oximetry
12%
Phorbol 13 Acetate 12 Myristate
12%
Group Therapy
12%
Proteasome
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
64%
Nuclear Factor
48%
Alternative Complement Pathway C3 C5 Convertase
48%
Dyspnea
36%
Randomized Controlled Trial
32%
Nitric Oxide
28%
Coughing
24%
Asthma
24%
Cyclooxygenase 2
24%
Lipoteichoic Acid
24%
Bronchiectasis
24%
Combination Therapy
24%
Disease
20%
Respiratory Failure
19%
Protein Kinase C
18%
Heart Failure
18%
Inflammation
16%
Bovine Serum Albumin
16%
Phorbol
15%
Carbon Dioxide
15%
Functional Status
15%
Carbon Black
14%
Intubation
14%
Staphylococcus Aureus
13%
Thrombin
12%
Experimental Liver Ischemia-Reperfusion Injury
12%
Breathing Disorder
12%
Prostaglandin Synthase
12%
Mitogen Activated Protein Kinase
12%
Amyotrophic Lateral Sclerosis
12%
Cohort Study
12%
Hypoxia
12%
Prostaglandin Synthase Inhibitor
12%
Obstructive Airway Disease
12%
Non Small Cell Lung Cancer
12%
Chronic Bronchitis
12%
Plasma Protein
12%
Sleep Disordered Breathing
12%
Epidermal Growth Factor Receptor Kinase Inhibitor
12%
Gastroesophageal Reflux
12%
Lipocortin 5
12%
Phosphatidylinositide
12%
Curcumin
12%
Heme Oxygenase 1
12%
Immunosuppressive Agent
12%
Ciclosporin
12%
Fibrinogen
12%
Protein Kinase B
12%
Carbon Monoxide
12%
Purinergic P2X Receptor
12%